๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Detection of prostate specific antigen in breast tumors

โœ Scribed by H. He; E.P. Diamandis; D.J.A. Sutherland


Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
124 KB
Volume
27
Category
Article
ISSN
0009-9120

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Immunoreactive prostate-specific antigen
โœ Michael Levesque; He Yu; Mario D'Costa; Latif Tadross; Dr. Eleftherios P. Diaman ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 413 KB

Prostate-specific antigen (PSA) is a glycoprotein produced by the epithelial cells of the prostate. PSA is currently used clinically to diagnose and monitor prostate carcinoma. In previous work we have demonstrated that 30% of breast tumors and, more rarely other tumors, contain significant amounts

Prostate-Specific antigen expression by
โœ Michael Levesque; He Hu; Eleftherios P. Diamandis; Mario D'Costa ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 568 KB

There is a growing body of evidence indicating that prostate-specific antigen (PSA) may be present in many steroid hormonestimulated epithelial tissues other than that of the prostate. In particular, breast tumor cell lines treated with steroid hormone receptor agonists, breast tumors, and normal hu

The use of prostate specific antigen den
โœ Paul R. Bretton; William P. Evans; James D. Borden; Ronald D. Castellanos ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 442 KB ๐Ÿ‘ 2 views

Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr